CFS
TRIB

CGC Financial Services’s Trinity Biotech TRIB Stock Holding History

CGC Financial Services’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-300
Closed -$612 – 365
2024
Q1 		$612 Hold
300
– – ﹤0.01% 315
2023
Q4 		$644 Hold
300
– – ﹤0.01% 324
2023
Q3 		$1.1K Hold
300
– – ﹤0.01% 270
2023
Q2 		$1.43K Buy
+300
New +$1.45K ﹤0.01% 277

Other funds holding TRIB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CGC Financial Services's TRIB Position: Q2 2024 in Review

CGC Financial Services sold out of Trinity Biotech (TRIB) in Q2 2024, closing a stake of 300 shares — an estimated $612 sold.

CGC Financial Services first reported a position in TRIB in Q2 2023 and held it in 4 quarters. The position peaked at $1.43K in Q2 2023. 20 funds tracked by Wall St. Rank hold TRIB as of Q2 2024.

  • CGC Financial Services reported no remaining Trinity Biotech position as of Q2 2024 after selling out during the quarter.
  • CGC Financial Services sold 300 Trinity Biotech shares in Q2 2024, an estimated $612.
  • CGC Financial Services first reported a position in Trinity Biotech in Q2 2023 and held it in 4 quarters.
  • CGC Financial Services's Trinity Biotech position peaked at $1.43K in Q2 2023.
  • 20 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2024.

Based on CGC Financial Services's 13F filing for Q2 2024, filed 17 Jul 2024.